SLR Investment Corp.

SLR Investment Corp. is a business development company that provides debt and equity financing to middle-market companies across the United States. The firm specializes in secured lending structures, including first lien, unitranche, and second lien loans, alongside subordinated debt and minority equity positions. The company also pursues control equity investments and participates in transactions supporting leveraged buyouts, acquisitions, recapitalizations, and growth capital initiatives.

The firm maintains a diversified investment approach across numerous sectors, including aerospace and defense, automotive, chemicals, financial services, healthcare, life sciences, manufacturing, retail, telecommunications, and utilities. Within life sciences, SLR focuses on specialty pharmaceuticals, medical devices, biotech, and healthcare providers and services. Typical portfolio investments range from $5 million to $100 million in companies with annual revenues between $50 million and $1 billion and EBITDA between $15 million and $100 million.

SLR structures its investments as senior secured loans, mezzanine debt, and equity securities, with an average holding period of approximately three years. The company may also invest in secondary transactions and thinly traded public securities. Based in New York and incorporated in Maryland, SLR operates as a publicly listed investment company on the Nasdaq.